Austin Lee Resourcing was founded with a clear sense of purpose to provide a high level service that is efficient, genuine and innovative to both our candidates and our clients. Our objective is to ...

Weinberg Group The Weinberg Group is the global leader in regulatory and compliance services. We have provided biotech, medical device and pharmaceutical consulting services for over 30 years. This is ...

3DforScience is a Scientific communication and medical animation company for the healthcare sector focused on helping pharmaceutical, biotechnology and healthcare companies for marketing actions ...

IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value ...

4C Consultants International is founded on a wealth of experience and expertise. 4C staff combine scientific skills and a flair for marketing and medical affairs with in-depth relevant pharmaceutical ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as an add-on maintenance treatment for chronic obstructive pulmonary ...

Pfizer’s Elrexfio (elranatamab) has been accepted by the Scottish Medicines Consortium (SMC) for use as a monotherapy in adults with relapsed and refractory multiple myeloma. The BCMA-directed ...

The World Health Organization (WHO) has declared the climate crisis one of the biggest global threats to human health. It currently estimates that one in four deaths can be attributed to preventable ...

Johnson & Johnson’s (J&J) dual-acting IL-23 inhibitor Tremfya (guselkumab) has been approved by the US Food and Drug Administration (FDA) to treat adults with moderately to severely active ulcerative ...

Gilead Sciences and artificial intelligence (AI)-focused Genesis Therapeutics have entered into a collaboration aimed at developing small molecule therapies across multiple targets. The partners will ...

Merck & Co – known as MSD outside the US and Canada – and Daiichi Sankyo’s investigational antibody-drug conjugate (ADC) ifinatamab deruxtecan has demonstrated promising results in a mid-stage lung ...

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ ...